119 related articles for article (PubMed ID: 38198666)
1. Promiscuity and Quantitative Contribution of UGT2B17 in Drug and Steroid Metabolism Determined by Experimental and Computational Approaches.
Ahire D; Mariasoosai C; Naji-Talakar S; Natesan S; Prasad B
J Chem Inf Model; 2024 Jan; 64(2):483-498. PubMed ID: 38198666
[TBL] [Abstract][Full Text] [Related]
2. Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism.
Zhang H; Basit A; Busch D; Yabut K; Bhatt DK; Drozdzik M; Ostrowski M; Li A; Collins C; Oswald S; Prasad B
Biochem Pharmacol; 2018 Oct; 156():32-42. PubMed ID: 30086285
[TBL] [Abstract][Full Text] [Related]
3. Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal Antibody.
Émond JP; Labriet A; Desjardins S; Rouleau M; Villeneuve L; Hovington H; Brisson H; Lacombe L; Simonyan D; Caron P; Périgny M; Têtu B; Fallon JK; Klein K; Smith PC; Zanger UM; Guillemette C; Lévesque E
Drug Metab Dispos; 2019 May; 47(5):444-452. PubMed ID: 30819787
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation.
Sten T; Finel M; Ask B; Rane A; Ekström L
Steroids; 2009 Nov; 74(12):971-7. PubMed ID: 19643121
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions
Kahma H; Filppula AM; Neuvonen M; Tarkiainen EK; Tornio A; Holmberg MT; Itkonen MK; Finel M; Neuvonen PJ; Niemi M; Backman JT
Drug Metab Dispos; 2018 Feb; 46(2):141-150. PubMed ID: 29138287
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia.
Gruber M; Bellemare J; Hoermann G; Gleiss A; Porpaczy E; Bilban M; Le T; Zehetmayer S; Mannhalter C; Gaiger A; Shehata M; Fleiss K; Skrabs C; Lévesque É; Vanura K; Guillemette C; Jaeger U
Blood; 2013 Feb; 121(7):1175-83. PubMed ID: 23169782
[TBL] [Abstract][Full Text] [Related]
7. Dimethandrolone, a Potential Male Contraceptive Pill, is Primarily Metabolized by the Highly Polymorphic UDP-Glucuronosyltransferase 2B17 Enzyme in Human Intestine and Liver.
Sharma S; Ahire D; Basit A; Lajoie M; Wang C; Lee MS; Blithe DL; Amory JK; Singh DK; Heyward S; Prasad B
Drug Metab Dispos; 2022 Dec; 50(12):1493-1500. PubMed ID: 36184078
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin.
Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W
J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805
[TBL] [Abstract][Full Text] [Related]
9.
Sulekha A; Osborne MJ; Gasiorek J; Borden KLB
Biomol NMR Assign; 2023 Jun; 17(1):67-73. PubMed ID: 36757531
[TBL] [Abstract][Full Text] [Related]
10. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
Turgeon D; Carrier JS; Lévesque E; Hum DW; Bélanger A
Endocrinology; 2001 Feb; 142(2):778-87. PubMed ID: 11159850
[TBL] [Abstract][Full Text] [Related]
11. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.
Bélanger A; Hum DW; Beaulieu M; Lévesque E; Guillemette C; Tchernof A; Bélanger G; Turgeon D; Dubois S
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):301-10. PubMed ID: 9699884
[TBL] [Abstract][Full Text] [Related]
12. Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics.
Turgeon D; Carrier JS; Chouinard S; Bélanger A
Drug Metab Dispos; 2003 May; 31(5):670-6. PubMed ID: 12695357
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex.
Bhatt DK; Basit A; Zhang H; Gaedigk A; Lee SB; Claw KG; Mehrotra A; Chaudhry AS; Pearce RE; Gaedigk R; Broeckel U; Thornton TA; Nickerson DA; Schuetz EG; Amory JK; Leeder JS; Prasad B
Drug Metab Dispos; 2018 Jun; 46(6):888-896. PubMed ID: 29602798
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity.
Gallagher CJ; Balliet RM; Sun D; Chen G; Lazarus P
Drug Metab Dispos; 2010 Dec; 38(12):2204-9. PubMed ID: 20810538
[TBL] [Abstract][Full Text] [Related]
15. Potential Assessment of UGT2B17 Inhibition by Salicylic Acid in Human Supersomes In Vitro.
Salhab H; Naughton DP; Barker J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361561
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Metabolism of Diclofenac by Polymorphic UGT2B17 Correlates with its Highly Variable Pharmacokinetics and Safety across Populations.
Ahire D; Heyward S; Prasad B
Clin Pharmacol Ther; 2023 Jul; 114(1):161-172. PubMed ID: 37042794
[TBL] [Abstract][Full Text] [Related]
17. Red wine and component flavonoids inhibit UGT2B17 in vitro.
Jenkinson C; Petroczi A; Naughton DP
Nutr J; 2012 Sep; 11():67. PubMed ID: 22958586
[TBL] [Abstract][Full Text] [Related]
18. Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype.
Balliet RM; Chen G; Gallagher CJ; Dellinger RW; Sun D; Lazarus P
Cancer Res; 2009 Apr; 69(7):2981-9. PubMed ID: 19318555
[TBL] [Abstract][Full Text] [Related]
19. Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.
Deshmukh N; Petróczi A; Barker J; Székely AD; Hussain I; Naughton DP
Subst Abuse Treat Prev Policy; 2010 Apr; 5():7. PubMed ID: 20429943
[TBL] [Abstract][Full Text] [Related]
20. Udp-glucuronosyltransferase 2b7 is the major enzyme responsible for gemcabene glucuronidation in human liver microsomes.
Bauman JN; Goosen TC; Tugnait M; Peterkin V; Hurst SI; Menning LC; Milad M; Court MH; Williams JA
Drug Metab Dispos; 2005 Sep; 33(9):1349-54. PubMed ID: 15980101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
